Director of Axsome Therapeutics, Inc. (U.S.: Nasdaq:AXSM), Saad Mark E, buys 300 shares worth $10,324
According to Axsome Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 19 07:30 AM, company Director, Saad Mark E disclosed buying 300 shares at a cost of $34.41. At the time of this transaction (Nov 17), this trade was worth $10,324 in total. As of Nov 17, Saad Mark E now owns 100 shares in total worth about $3,790.9999999999995.
For the last few recent trades made by Axsome Therapeutics, Inc. (U.S.: Nasdaq:AXSM) Director, Saad Mark E, we have the following information:
- SEC Form 4 filing: Nov 17: Bought 3,000 shares at the rate of $34.53 per share. Total worth of this trade was $103,597. Total number of shares owned as of Nov 17 were 10,002
- SEC Form 4 filing: May 23: Bought 3,500 shares at the rate of $22.33 per share. Total worth of this trade was $78,155. Total number of shares owned as of May 23 were 7,002
Posted by
George Daniels
on Friday November 19 2021, 10:28 AM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
